- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe dry eye syndrome
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 843KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 53KB)
Polyethylene glycol 400 with propylene glycol – November 2021
Polyethylene glycol 400 with propylene glycol: Eye drops 4mg-3mg per mL, single dose units 0.8 mL, 30; Systane®
Last updated
4 March 2022